Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

CASI Pharmaceuticals Inc

CASI
2,225
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 09:00:03
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/2/202514:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/1/202514:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/1/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
26/12/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/12/202422:16EDGAR2Form F-3/A - Registration statement by foreign private..
20/12/202423:26EDGAR2Form F-3 - Registration statement by foreign private issuers
16/12/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202413:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/9/202414:00PRNUSCASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C...
29/8/202414:00EDGAR2Form F-3/A - Registration statement by foreign private..
16/8/202423:01EDGAR2Form F-3 - Registration statement by foreign private issuers
16/8/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/8/202414:00PRNUSCASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS..
14/8/202412:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/7/202423:30PRNUSCASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS..
19/7/202412:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/7/202413:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/7/202413:30PRNUSCASI Pharmaceuticals announces appointment of Daniel Lang,..
26/6/202422:15PRNUSCASI Pharmaceuticals Announces Plan To Submit IND..
26/6/202422:10PRNUSCASI Pharmaceuticals Announces $15 Million Private Placement..
15/5/202414:00PRNUSCASI Pharmaceuticals Receives FDA Clearance On The..
15/5/202412:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/5/202414:00PRNUSCASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS..
08/4/202423:00PRNUSCASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS..
28/3/202412:00PRNUSCASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR..
Apertura: Min: Max:
Chiusura: 2,225

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network